Dáil Éireann Debate, Tuesday - 28 June 2022
755. Deputy Joe O'Brien asked the Minister for Health the status of talks between the HSE and an organisation (details supplied) in relation to the life-changing cystic fibrosis drug therapy kaftrio to make this drug therapy available to 35 children with cystic fibrosis aged between six and eleven years; and if he will make a statement on the matter. [33672/22]
View answer868. Deputy James Lawless asked the Minister for Health if there are plans to provide children with cystic fibrosis with the drug kaftrio; if not, the reasons for not providing this drug; if there are any plans in the future to provide this drug; and if he will make a statement on the matter. [34274/22]
View answer882. Deputy Alan Farrell asked the Minister for Health if the HSE is considering funding kaftrio, which is used to treat cystic fibrosis patients; and if he will make a statement on the matter. [34338/22]
View answerI propose to take Questions Nos. 755, 868 and 882 together.
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
